|
1
|
Guo JD, Li L, Shi YM, Wang HD and Hou SX:
Hydrogen water consumption prevents osteopenia in ovariectomized
rats. Br J Pharmacol. 168:1412–1420. 2013. View Article : Google Scholar :
|
|
2
|
Das S and Crockett JC: Osteoporosis - a
current view of pharmacological prevention and treatment. Drug Des
Devel Ther. 7:435–448. 2013.PubMed/NCBI
|
|
3
|
Yang Y, Wang B, Fei Q, et al: Validation
of an osteoporosis self-assessment tool to identify primary
osteoporosis and new osteoporotic vertebral fractures in
postmenopausal Chinese women in Beijing. BMC Musculoskelet Disord.
14:2712013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pervaiz S: Resveratrol: from grapevines to
mammalian biology. FASEB J. 17:1975–1985. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baur JA and Sinclair DA: Therapeutic
potential of resveratrol: the in vivo evidence. Nat Rev Drug
Discov. 5:493–506. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karuppagounder SS, Pinto JT, Xu H, Chen
HL, Beal MF and Gibson GE: Dietary supplementation with resveratrol
reduces plaque pathology in a transgenic model of Alzheimer’s
disease. Neurochem Int. 54:111–118. 2009. View Article : Google Scholar
|
|
7
|
Mizutani K, Ikeda K, Kawai Y and Yamori Y:
Resveratrol stimulates the proliferation and differentiation of
osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun.
253:859–863. 1998. View Article : Google Scholar
|
|
8
|
Liu ZP, Li WX, Yu B, et al: Effects of
trans-resveratrol from Polygonum cuspidatum on bone loss using the
ovariectomized rat model. J Med Food. 8:14–19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNAs and
chromosomal abnormalities in cancer cells. Oncogene. 25:6202–6210.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kiesslich T, Alinger B, Wolkersdörfer GW,
Ocker M, Neureiter D and Berr F: Active Wnt signalling is
associated with low differentiation and high proliferation in human
biliary tract cancer in vitro and in vivo and is sensitive to
pharmacological inhibition. Int J Oncol. 36:49–58. 2010.
|
|
11
|
Thompson JD, Higgins DG and Gibson TJ:
CLUSTAL W: improving the sensitivity of progressive multiple
sequence alignment through sequence weighting, position-specific
gap penalties and weight matrix choice. Nucleic Acids Res.
22:4673–4680. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
D’Souza RN, Aberg T, Gaikwad J, et al:
Cbfa1 is required for epithelial-mesenchymal interactions
regulating tooth development in mice. Development. 126:2911–2920.
1999.
|
|
13
|
Miyazaki T, Kanatani N, Rokutanda S, et
al: Inhibition of the terminal differentiation of odontoblasts and
their transdifferentiation into osteoblasts in Runx2 transgenic
mice. Arch Histol Cytol. 71:131–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li S, Kong H, Yao N, et al: The role of
runt-related transcription factor 2 (Runx2) in the late stage of
odontoblast differentiation and dentin formation. Biochem Biophys
Res Commun. 410:698–704. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee KS, Kim HJ, Li QL, et al: Runx2 is a
common target of transforming growth factor beta1 and bone
morphogenetic protein 2 and cooperation between Runx2 and Smad5
induces osteoblast-specific gene expression in the pluripotent
mesenchymal precursor cell line C2C12. Mol Cell Biol. 20:8783–8792.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu H, Sun Q, Wan C, Li L, Zhang L and
Chen Z: MicroRNA-338-3p regulates osteogenic differentiation of
mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2.
J Cell Physiol. 229:1494–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Q, Liu H, Lin H, Yuan G, Zhang L and
Chen Z: MicroRNA-338-3p promotes differentiation of mDPC6T into
odontoblast-like cells by targeting Runx2. Mol Cell Biochem.
377:143–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Govoni KE, Wergedal JE, Chadwick RB,
Srivastava AK and Mohan S: Prepubertal OVX increases IGF-1
expression and bone accretion in C57BL/6 mice. Am J Physiol
Endocrinol Metab. 295:E1172–E1180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mizutani K, Ikeda K, Kawai Y and Yamori Y:
Resveratrol attenuates ovariectomy-induced hypertension and bone
loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci
Vitaminol (Tokyo). 46:78–83. 2000. View Article : Google Scholar
|
|
21
|
Casarin RC, Casati MZ, Pimentel SP, et al:
Resveratrol improves bone repair by modulation of bone
morphogenetic proteins and osteopontin gene expression in rats. Int
J Oral Maxillofac Surg. 43:900–906. 2014. View Article : Google Scholar : PubMed/NCBI
|
